USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 3, 2022 | Jun 2022 | $0.29 | - | $0.38 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 3, 2022 | Jun 2022 | $716.74M | $706.20M | $617.02M |
Adapthealth Corp's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 7 | $0.29 | $0.23 | $0.35 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 7 | $1.19 | $0.84 | $1.75 |
| Dec 2023 | 7 | $1.58 | $1.16 | $1.85 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 1 / 0 | $0.27 | $0.27 | $0.33 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 1 / 1 | $1.13 | $1.13 | $1.38 |
| Dec 2023 | 1 / 1 | $1.56 | $1.56 | $1.76 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 10 | $716.74M | $687.40M | $762.63M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 10 | $2.92B | $2.87B | $2.97B |
| Dec 2023 | 10 | $3.23B | $3.12B | $3.35B |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 10, 2022 | Mar 2022 | $0.18 | - | - |
| Feb 24, 2022 | Dec 2021 | $0.34 | $0.17 | -50.00% |
| Nov 4, 2021 | Sep 2021 | $0.39 | $0.37 | -6.40% |
| Aug 5, 2021 | Jun 2021 | $0.26 | $0.38 | 45.95% |
| May 6, 2021 | Mar 2021 | $0.26 | $0.20 | -23.53% |
| Mar 4, 2021 | Dec 2020 | $0.23 | $0.44 | 93.25% |
| Nov 4, 2020 | Sep 2020 | $0.13 | $0.21 | 67.09% |
| Aug 4, 2020 | Jun 2020 | $0.16 | $0.16 | -1.48% |
| May 5, 2020 | Mar 2020 | $0.08 | $0.02 | -73.33% |
| Feb 25, 2020 | Dec 2019 | $0.10 | $0.08 | -21.02% |
| Nov 13, 2019 | Sep 2019 | - | $-0.00 | - |
| Mar 31, 2019 | Mar 2019 | - | $0.03 | - |
| Dec 31, 2018 | Dec 2018 | - | $0.02 | - |
| Sep 30, 2018 | Sep 2018 | - | $0.02 | - |
| Jun 30, 2018 | Jun 2018 | - | $0.02 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 24, 2022 | Dec 2021 | $1.12 | $1.11 | -0.51% |
| Mar 4, 2021 | Dec 2020 | $0.23 | $0.83 | 261.52% |
| Feb 25, 2020 | Dec 2019 | $0.09 | $0.10 | 8.22% |
| Dec 31, 2018 | Dec 2018 | - | $0.06 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 10, 2022 | Mar 2022 | $651.46M | $706.20M | 1.08% |
| Feb 24, 2022 | Dec 2021 | $689.87M | $702.11M | 1.02% |
| Nov 4, 2021 | Sep 2021 | $637.68M | $653.29M | 1.02% |
| Aug 5, 2021 | Jun 2021 | $617.02M | $617.02M | 1.00% |
| May 6, 2021 | Mar 2021 | $486.34M | $482.12M | 0.99% |
| Mar 4, 2021 | Dec 2020 | $323.09M | $348.43M | 1.08% |
| Nov 4, 2020 | Sep 2020 | $265.31M | $284.40M | 1.07% |
| Aug 4, 2020 | Jun 2020 | $196.28M | $232.12M | 1.18% |
| May 5, 2020 | Mar 2020 | $177.40M | $191.44M | 1.08% |
| Feb 25, 2020 | Dec 2019 | $142.26M | $529.64M | 3.72% |
| Nov 13, 2019 | Sep 2019 | - | $0.00 | - |
| Mar 31, 2019 | Mar 2019 | - | $119.50M | - |
| Dec 31, 2018 | Dec 2018 | - | $105.40M | - |
| Sep 30, 2018 | Sep 2018 | - | $102.16M | - |
| Jun 30, 2018 | Jun 2018 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 24, 2022 | Dec 2021 | $2.44B | $2.45B | 0.62% |
| Mar 4, 2021 | Dec 2020 | $1.03B | $1.06B | 2.48% |
| Feb 25, 2020 | Dec 2019 | $522.33M | $529.64M | 1.40% |
| Dec 31, 2018 | Dec 2018 | - | $0.00 | - |
AHCO's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.
According to analysts, the average EPS estimation for Adapthealth Corp's next quarterly earnings is $0.29, with a low EPS estimation of $0.23, and a high estimation of $0.35.
Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $0.27, the last 2 month trend is $0.27, and the 3 month trend is $0.33.
Based on analysts, the average revenue estimation is $716.74M, with a low revenue estimation of $687.40M, and a high estimation of $762.63M.
Adapthealth Corp's previous earnings date was May 10, 2022 for its fiscal quarter ended Mar 31, 2022.
Revenues were $706.20M, better than the forecast of $651.46M by 8.40%, up by 0.58% from the previous quarter , and up by 46.48% from the same period last year.
The company reported a net income of $41.75M.Free cash flow for the quarter was $-10.71M , compared to $37.31M last quarter and $-17.22M a year before.
AHCO ended the quarter with $2.35B in total debt, a decrease of -0.68% compared to the previous quarter, and an increase of 31.79% compared to the same quarter a year before.
Adapthealth Corp's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.
AHCO's earnings per share (EPS) was $1.11, missing the consensus analysts forecast of $1.12 by -0.51% , and higher than the previous year's EPS (Dec 2020) by 34.01%.
Revenues were $2.45B, better than the forecast of $2.44B by 0.62%, and up by 132.35% from previous year's revenue.
The company reported a net income of $156.18M.
Adapthealth Corp reported a free cash flow of $72.37M for its fiscal year, compared to $155.88M a year ago.
The company ended the fiscal year with $2.37B in total debt, an increase of 193.76% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
